Neogen Corp. (NEOG)
7.005
+0.02
(+0.21%)
USD |
NASDAQ |
Jan 02, 12:30
Neogen EPS Diluted (Quarterly): 0.1672 for Aug. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ResMed, Inc. | 2.373 |
| Myriad Genetics, Inc. | -0.2943 |
| Amgen, Inc. | 5.934 |
| Tandem Diabetes Care, Inc. | -0.3128 |
| Outlook Therapeutics, Inc. | -0.5453 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 36.34M |
| Revenue (Quarterly) | 209.19M |
| Total Expenses (Quarterly) | 172.85M |
| Enterprise Value | 2.173B |
| Gross Profit Margin (Quarterly) | 34.40% |
| Profit Margin (Quarterly) | 17.37% |
| Earnings Yield | -68.64% |
| Operating Earnings Yield | 0.34% |
| Normalized Earnings Yield | -18.72 |